The use of positron emission tomography/CT in the diagnosis of tuberculosis-associated uveitis

British Journal of Ophthalmology

Volumn 95, Issue 9, 2011, Pages 1290-1294

  Doycheva, Deshka ^a   Deuter, Christoph ^a   Hetzel, Juergen ^b   Frick, Julia Stefanie ^b   Aschoff, Phillip ^b   Schuelen, Eva ^b   Zierhut, Manfred ^a   Pfannenberg, Christina ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; FLUORODEOXYGLUCOSE F 18; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STEROID; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BRONCHOSCOPY; CHOROIDITIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG UPTAKE; DRUG WITHDRAWAL; EYE INFLAMMATION; HUMAN; INTERFERON GAMMA RELEASE ASSAY; IRIDOCYCLITIS; LUNG CALCIFICATION; LUNG GRANULOMA; LUNG HILUS; LUNG LESION; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; MEDIASTINUM LYMPH NODE; MULTIFOCAL CHOROIDITIS; MYCOBACTERIUM TUBERCULOSIS; OCULAR TUBERCULOSIS; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENCE RISK; RELAPSE; REMISSION; RETINA VASCULITIS; SCREENING; SERPIGINOUS CHOROIDITIS; TRACHEOBRONCHIAL TOILET; TRANSBRONCHIAL ASPIRATION; UNSPECIFIED SIDE EFFECT; UVEITIS;

ADULT; AGED; BIOPSY; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TUBERCULOSIS, OCULAR; UVEITIS; YOUNG ADULT;

EID: 80052115119     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2010.182659     Document Type: Article

References (22)

1. Day C, Scheele S, Dolin P, et al. Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999;282:677-86.
2. Centers for Disease Control and Prevention. Trends in tuberculosis in United States, 2004. MMWR Morb Mortal Wkly Rep 2005;54:245-9.
3. Farhat M, Greenaway C, Pai M, et al. False-positive tuberculin skin tests: what is the absolute effect of BCG and nontuberculous mycobacteria? Int J Tuberc Lung Dis 2006;10:1192-204. (Pubitemid 44713473)
4. Pai M, Riley LW, Colford JM Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004;4:761-76.
5. Menzies D, Pai M, Comstock G. New tests for diagnosis of latent tuberculosis infection: Areas of uncertainty and recommendations for research. Ann Int Med 2007;146:340-54. (Pubitemid 351650594)
6. Surti S, Karp JS, Kinahan PE. PET instrumentation. Radiol Clin North Am 2004;42:1003-16. (Pubitemid 39361457)
7. Kubota R, Kubota K, Yamada S, et al. Microautoradiolographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J Nucl Med 1994;35:104-12. (Pubitemid 24018451)
8. Bybel B, Brunken RC, Shah SN, et al. PET and PET/CT imaging: What clinicians need to know. Cleve Clin J Med 2006;73:1075-87. (Pubitemid 44883983)
9. Bakheet S, Powe J, Ezzat A, et al. F-18-FDG uptake in tuberculosis. Clin Nucl Med 1998;23:739-42.
10. Hofmeyr A, Eddie Lau WF, Slavin MA. Mycobacterium tuberculosis infection in patients with cancer, the role of 18-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring treatment response. Tuberculosis 2007;87:459-63. (Pubitemid 47314357)
11. Tannen BL, Ghesani NV, Frohman L, et al. Use of whole-body FDG PET-CT to aid in the diagnosis of ocular sarcoidosis. Ocul Immunol Inflamm 2008;16:25-7. (Pubitemid 351480325)
12. Shulman JP, Latkany P, Cjin KJ, et al. Whole-body 18FDG PET-CT imaging of systemic sarcoidosis: ophthalmic oncology and uveitis. Ocul Immunol Inflamm 2009;17:95-100.
13. Seve P, Billotey C, Janier M, et al. Fluorodeoxyglucose positron emission tomography for the diagnosis of sarcoidosis in patients with unexplained chronic uveitis. Ocul Immunol Inflamm 2009;17:179-84.
14. Mazureck GH, Jereb J, Lobue P, et al. Division of tuberculosis elimination, National Center for HIV, STD and TB prevention, Centers for Disease Control and Prevention. Guidelines for using the QuantiFERON-TB Gold test for detection of Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005;54:49-55.
15. Vasconcelos-Santos DV, Zierhut M, Rao NA. Strengths and weaknesses of diagnostic tools for tuberculous uveitis. Ocular Immunol Inflam 2009;17:351-5.
16. Gupta V, Gupta A, Arora S, et al. Presumed tubercular serpiginous-like choroiditis. Ophthalmology 2003;110:1744-9.
17. Gupta A, Gupta V, Arora S, et al. PCR-positive tubercular retinal vasculitis. Retina 2001;21:435-44.
18. Gupta V, Gupta A, Rao NA. Intraocular tuberculosis - An update. Surv Ophthalmol 2007;52:561-87.
19. Biswas J, Therese L, Madhavan HN. Use of polymerase chain reaction in detection of Mycobacterium tuberculosis complex DNA from vitreous sample of Eales' disease. Br J Ophthalmol 1999;83:994. (Pubitemid 29376046)
20. Bodaghi B, LeHoang P. Ocular tuberculosis (review). Curr Opin Ophthalmol 2000;11:443-8.
21. Varma D, Anand S, Reddy AR, et al. Tuberculosis: an under-diagnosed aetiological agent in uveitis with an effective treatment. Eye 2006;20:1068-73. (Pubitemid 44340328)
22. 18F-FDG-PET/CT), aspiration biopsy and culture. Ocul Immunol Inflamm 2010;18:194-9.